62Indexed trials
Market Rank #43 · Evidence Tier A
Bulgaria
Neuroscience Intelligence
Bulgaria neuroscience intelligence: 62 indexed trials, 15 institutions, research score 28.09.
12Recruiting
15Research institutions
28.1Research score
Evidence profile
42Sponsors
17Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 28.1 · Data confidence 100.00 · Evidence 28.1
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
epilepsy15trials
multiple_sclerosis9trials
parkinsons8trials
alzheimers6trials
schizophrenia4trials
depression4trials
neurodevelopmental_other2trials
bipolar_disorder2trials
neuromuscular2trials
other_psychiatry2trials
Leading indexed sponsors
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4trials
Boehringer Ingelheim3trials
Hoffmann-La Roche3trials
UCB Pharma3trials
H. Lundbeck A/S3trials
Sanofi2trials
Novo Nordisk A/S2trials
Celgene2trials
ACADIA Pharmaceuticals Inc.2trials
Otsuka Pharmaceutical Development & Commercialization, Inc.2trials